Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma

Fig. 6

Immunohistochemical staining of FERMT2, FKBP3, SMAD9, GATA2 and IHITH4 protein in LUAD tissues (magnification, × 200). A1:weak expression of FERMT2;A2:moderate expression of FERMT2;A3:strong expression of FERMT2; B1:weak expression of FKBP3; B2:moderate expression of FKBP3;B3:strong expression of FKBP3;C1:weak expression of GATA2;C2:moderate expression of GATA2; C3:strong expression of GATA2;D1weak expression of IHITH4;D2:moderate expression of IHITH4;D3:strong expression of IHITH4; E1:weak expression of SMAD9;E2:moderate expression of SMAD9;E3:strong expression of SMAD9

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us